Raphael E Pollock Selected Research

Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)

9/2008	Combined vascular endothelial growth factor receptor/epidermal growth factor receptor blockade with chemotherapy for treatment of local, uterine, and metastatic soft tissue sarcoma.
4/2002	Combined anti-fetal liver kinase 1 monoclonal antibody and continuous low-dose doxorubicin inhibits angiogenesis and growth of human soft tissue sarcoma xenografts by induction of endothelial cell apoptosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Raphael E Pollock Research Topics

Disease

79	Neoplasms (Cancer) 01/2024 - 04/2002
64	Sarcoma (Soft Tissue Sarcoma) 01/2024 - 04/2002
21	Liposarcoma 01/2024 - 04/2012
19	Neoplasm Metastasis (Metastasis) 11/2023 - 08/2002
10	Aggressive Fibromatosis (Desmoid) 01/2022 - 05/2007
9	Neurofibrosarcoma (MPNST) 01/2018 - 05/2009
9	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 08/2014 - 12/2003
8	Leiomyosarcoma 05/2016 - 11/2005
7	Breast Neoplasms (Breast Cancer) 01/2016 - 04/2002
3	Carcinogenesis 01/2023 - 03/2015
3	Margins of Excision 06/2020 - 05/2003
3	Wounds and Injuries (Trauma) 09/2016 - 09/2006
3	Genomic Instability 03/2016 - 01/2011
2	Necrosis 01/2024 - 08/2004
2	Ewing Sarcoma (Sarcoma, Ewing) 10/2018 - 11/2009
2	Neurofibroma 01/2018 - 06/2009
2	Carcinoma (Carcinomatosis) 11/2015 - 11/2005
2	Hemangiosarcoma (Angiosarcoma) 04/2013 - 12/2005
2	Myxoid Liposarcoma 12/2012 - 03/2008
2	Lymphatic Metastasis 04/2009 - 04/2008
2	Fibrosarcoma 09/2008 - 05/2008
2	Synovial Sarcoma (Synovioma) 11/2007 - 02/2005
2	Disease Progression 01/2007 - 08/2003
2	Fibrosis (Cirrhosis) 07/2002 - 05/2002
1	Retroperitoneal liposarcoma 11/2023
1	Ataxia Telangiectasia (Louis Bar Syndrome) 01/2022
1	Colonic Neoplasms (Colon Cancer) 05/2019
1	Cachexia 12/2018
1	Pancreatic Neoplasms (Pancreatic Cancer) 12/2018
1	Lewis Lung Carcinoma 12/2018
1	Desmoplastic Small Round Cell Tumor 10/2018
1	Warts (Wart) 10/2018
1	Neurofibromatoses (Neurofibromatosis) 01/2018

Drug/Important Bio-Agent (IBA)

12	Proteins (Proteins, Gene)FDA Link 01/2016 - 02/2005
10	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2023 - 01/2002
10	Biomarkers (Surrogate Marker)IBA 01/2023 - 12/2011
9	Imatinib Mesylate (Gleevec)FDA Link 01/2011 - 12/2003
8	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 07/2013 - 04/2002
7	CateninsIBA 01/2022 - 04/2012
5	ParaffinIBA 07/2013 - 01/2005
4	MicroRNAs (MicroRNA)IBA 01/2023 - 04/2012
4	Phosphotransferases (Kinase)IBA 01/2022 - 04/2002
4	Messenger RNA (mRNA)IBA 01/2019 - 11/2006
4	SurvivinIBA 01/2018 - 12/2011
4	ErbB Receptors (EGF Receptor)IBA 01/2018 - 02/2005
3	DNA (Deoxyribonucleic Acid)IBA 01/2024 - 01/2014
3	Small Interfering RNA (siRNA)IBA 01/2022 - 11/2010
3	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 09/2008 - 04/2002
2	Proto-Oncogene Proteins c-mdm2IBA 01/2024 - 01/2020
2	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 10/2022 - 02/2005
2	SAR405838IBA 01/2022 - 03/2016
2	Interleukin-6 (Interleukin 6)IBA 01/2020 - 01/2017
2	Sorafenib (BAY 43-9006)FDA Link 01/2019 - 08/2012
2	Histone Deacetylase InhibitorsIBA 01/2016 - 05/2009
2	Enhancer of Zeste Homolog 2 ProteinIBA 03/2015 - 01/2014
2	3' Untranslated Regions (3' UTR)IBA 03/2015 - 02/2014
2	Tyrosine Kinase InhibitorsIBA 08/2014 - 09/2008
2	Histones (Histone)IBA 01/2014 - 05/2009
2	Cadherins (E-Cadherin)IBA 10/2013 - 11/2010
2	Formaldehyde (Formol)FDA Link 07/2013 - 12/2007
2	Ifosfamide FDA LinkGeneric 12/2012 - 09/2002
2	Cyclin D1IBA 04/2012 - 05/2009
2	PlasticsIBA 11/2011 - 10/2004
2	Complement System Proteins (Complement)IBA 01/2011 - 02/2007
2	Platelet-Derived Growth Factor beta Receptor (Receptor, Platelet Derived Growth Factor beta)IBA 08/2010 - 11/2009
2	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 09/2008 - 04/2002
2	LigandsIBA 05/2008 - 03/2008
2	Monoclonal AntibodiesIBA 09/2006 - 04/2002
1	CollagenIBA 01/2024
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 11/2023
1	palbociclibIBA 11/2023
1	matrigelIBA 05/2023
1	Transfer RNA (tRNA)IBA 01/2023
1	Small Untranslated RNAIBA 01/2023
1	berzosertibIBA 01/2022
1	Protein Kinases (Protein Kinase)IBA 01/2022
1	SynaptophysinIBA 02/2021
1	DesminIBA 02/2021
1	Dihydrotachysterol (AT 10)IBA 01/2020
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 05/2019
1	Leucovorin (Folinic Acid)FDA Link 05/2019
1	Fluorouracil (Carac)FDA LinkGeneric 05/2019
1	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 01/2019
1	Caspase 3 (Caspase-3)IBA 12/2018
1	Toll-Like Receptor 7IBA 12/2018
1	Cisplatin (Platino)FDA LinkGeneric 10/2018
1	Neurofibromin 2 (Merlin)IBA 01/2018

Therapy/Procedure

50	Therapeutics 11/2023 - 01/2002
26	Radiotherapy 01/2024 - 04/2002
13	Drug Therapy (Chemotherapy) 05/2023 - 04/2002
7	Neoadjuvant Therapy 06/2020 - 09/2002
2	Limb Salvage 06/2020 - 10/2004
2	Adjuvant Chemotherapy 01/2020 - 12/2003
2	Surgical Amputation (Amputations) 08/2017 - 08/2002
2	Laparotomy 04/2006 - 08/2003
1	Combined Modality Therapy 01/2023
1	Rehabilitation 12/2022
1	Palliative Care (Palliative Therapy) 01/2020
1	Cytoreduction Surgical Procedures 10/2018
1	Hyperthermic Intraperitoneal Chemotherapy 10/2018